{"id":"W2949268801","doi":"10.1136/annrheumdis-2019-eular.3110","title":"SAT0120 COMPARATIVE EFFECTIVENESS OF TOFACITINIB AND TNF INHIBITORS SINCE 2014. IMPACT OF COMBINATION WITH METHOTREXATE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Adalimumab; Golimumab; Tofacitinib; Etanercept; Infliximab; Certolizumab pegol; Ustekinumab; Internal medicine; Rheumatoid arthritis; Concomitant; Abatacept; Discontinuation; Methotrexate; Psoriatic arthritis; Oncology; Tumor necrosis factor alpha; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001802122,0.0005016754,0.001542622,0.0005282482,0.0001873789,0.001171428,0.0006803861,0.0008654724,0.007875931],"category_scores_gemma":[0.002790633,0.000233803,0.003741737,0.000905199,0.0004185261,0.0009146685,0.0003493497,0.002160607,0.001101041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001362086,"about_ca_system_score_gemma":0.001232768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003325684,"about_ca_topic_score_gemma":0.008985348,"domain_scores_codex":[0.9989429,0.0004463241,0.000141786,0.0001167052,0.0001503498,0.000201894],"domain_scores_gemma":[0.9983389,0.0005378281,0.000506444,0.00006980103,0.0001605651,0.0003864197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7028269,0.002316286,0.00943645,0.003158049,0.007814911,0.0002093604,0.00006784482,0.0021472,0.004854504,0.001097953,0.01213266,0.253938],"study_design_scores_gemma":[0.317714,0.3600032,0.2068534,0.00238637,0.03560384,0.00265604,0.0005289683,0.003444359,0.004797345,0.001238297,0.06457166,0.0002025509],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7538033,0.2070231,0.0003112894,0.003576277,0.002319786,0.0002039932,0.008518597,0.0000958807,0.02414789],"genre_scores_gemma":[0.9437996,0.03703647,0.0003688947,0.001657272,0.001359283,0.0001138646,0.01007933,0.00002400066,0.005561306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007875931,"threshold_uncertainty_score":0.02634758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02853048525797616,"score_gpt":0.3454046949609,"score_spread":0.3168742097029239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}